Literature DB >> 19088204

Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics.

Andrew S Goldstein1, Devon A Lawson, Donghui Cheng, Wenyi Sun, Isla P Garraway, Owen N Witte.   

Abstract

The epithelium of the adult prostate contains 3 distinct cell types: basal, luminal, and neuroendocrine. Tissue-regenerative activity has been identified predominantly from the basal cells, isolated by expression of CD49f and stem cell antigen-1 (Sca-1). An important question for the field is whether all basal cells have stem cell characteristics. Prostate-specific microarray databases were interrogated to find candidate surface antigens that could subfractionate the basal cell population. Tumor-associated calcium signal transducer 2 (TACSTD2/Trop2/M1S1/GA733-1) was identified because it was enriched after castration, in prostate sphere cells and in the basal fraction. In the murine prostate, Trop2 shows progenitor characteristics such as localization to the region of the gland proximal to the urethra and enrichment for sphere-forming and colony-forming cells. Trop2 subfractionates the basal cells into 2 populations, both of which express characteristic basal cell markers by quantitative PCR. However, only the basal cells expressing high levels of Trop2 were able to efficiently form spheres in vitro. In the human prostate, where Sca-1 is not expressed, sphere-forming progenitor cells were also isolated based on high expression of Trop2 and CD49f. Trop2-expressing murine basal cells could regenerate prostatic tubules in vivo, whereas the remaining basal cells had minimal activity. Evidence was found for basal, luminal, and neuroendocrine cells in prostatic tubules regenerated from Trop2(hi) basal cells. In summary, functionally distinct populations of cells exist within the prostate basal compartment and an epithelial progenitor can give rise to neuroendocrine cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088204      PMCID: PMC2603432          DOI: 10.1073/pnas.0811411106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; Holly Barker; Richard Thomas; Mark Shackleton; Natasha C Forrest; Lynne Hartley; Lorraine Robb; Frank G Grosveld; Jacqueline van der Wees; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

3.  Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.

Authors:  Ilaria Malanchi; Hector Peinado; Deepika Kassen; Thomas Hussenet; Daniel Metzger; Pierre Chambon; Marcel Huber; Daniel Hohl; Amparo Cano; Walter Birchmeier; Joerg Huelsken
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

4.  Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers.

Authors:  Jianbo Wang; Ryan Day; Yiyu Dong; Steven J Weintraub; Loren Michel
Journal:  Mol Cancer Ther       Date:  2008-02       Impact factor: 6.261

5.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

6.  A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.

Authors:  Emanuela Guerra; Marco Trerotola; Roberta Dell' Arciprete; Veronica Bonasera; Barbara Palombo; Tarek El-Sewedy; Tommaso Ciccimarra; Carlo Crescenzi; Franco Lorenzini; Cosmo Rossi; Giovanna Vacca; Rossano Lattanzio; Mauro Piantelli; Saverio Alberti
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 7.  Prostate epithelial cell fate.

Authors:  Robert J Matusik; Ren Jie Jin; Qian Sun; Yongqing Wang; Xiuping Yu; Aparna Gupta; Srinivas Nandana; Thomas C Case; Manik Paul; Janni Mirosevich; Siam Oottamasathien; John Thomas
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

8.  Self-renewal and multilineage differentiation in vitro from murine prostate stem cells.

Authors:  Li Xin; Rita U Lukacs; Devon A Lawson; Donghui Cheng; Owen N Witte
Journal:  Stem Cells       Date:  2007-07-19       Impact factor: 6.277

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

Review 10.  EpCAM (CD326) finding its role in cancer.

Authors:  P A Baeuerle; O Gires
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

View more
  181 in total

1.  The complexities of identifying a cell of origin for human prostate cancer.

Authors:  Gail P Risbridger; Renea A Taylor
Journal:  Asian J Androl       Date:  2010-10-18       Impact factor: 3.285

Review 2.  The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

Authors:  Katarzyna Marcinkiewicz; Kymora B Scotland; Stephen A Boorjian; Emeli M Nilsson; Jenny Liao Persson; Per Anders Abrahamsson; Cinzia Allegrucci; Ieuan A Hughes; Lorraine J Gudas; Nigel P Mongan
Journal:  Int J Oncol       Date:  2011-09-28       Impact factor: 5.650

3.  Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.

Authors:  Xi Wang; Min Long; Ke Dong; Fang Lin; Yuanyuan Weng; Yongri Ouyang; Li Liu; Junxia Wei; Xi Chen; Ting He; Hui-Zhong Zhang
Journal:  Cancer Biol Ther       Date:  2013-09-04       Impact factor: 4.742

4.  Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.

Authors:  Hsiang-Yu Lin; Yi-Chiu Kuo; Yu-I Weng; I-Lu Lai; Tim H-M Huang; Shuan-Pei Lin; Dau-Ming Niu; Ching-Shih Chen
Journal:  Prostate       Date:  2012-04-26       Impact factor: 4.104

5.  Repair and regeneration of tracheal surface epithelium and submucosal glands in a mouse model of hypoxic-ischemic injury.

Authors:  Ahmed E Hegab; Derek W Nickerson; Vi Luan Ha; Daphne O Darmawan; Brigitte N Gomperts
Journal:  Respirology       Date:  2012-10       Impact factor: 6.424

6.  A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.

Authors:  Marian Grade; Amanda B Hummon; Jordi Camps; Georg Emons; Melanie Spitzner; Jochen Gaedcke; Patrick Hoermann; Reinhard Ebner; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Tim Beissbarth; Natasha J Caplen; Thomas Ried
Journal:  Int J Cancer       Date:  2011-03-01       Impact factor: 7.396

7.  Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.

Authors:  Xiaoming Ju; Mathew C Casimiro; Michael Gormley; Hui Meng; Xuanmao Jiao; Sanjay Katiyar; Marco Crosariol; Ke Chen; Min Wang; Andrew A Quong; Michael P Lisanti; Adam Ertel; Richard G Pestell
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

8.  Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Authors:  Jennifer A Freedman; Yanru Wang; Xuechan Li; Hongliang Liu; Patricia G Moorman; Daniel J George; Norman H Lee; Terry Hyslop; Qingyi Wei; Steven R Patierno
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

9.  A developmental stage-dependent switch of the mechanisms for prostate epithelial maintenance.

Authors:  Li Xin
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

10.  Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.

Authors:  Marco Trerotola; Danielle L Jernigan; Qin Liu; Javed Siddiqui; Alessandro Fatatis; Lucia R Languino
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.